M&A · Healthcare · Biological Products, (No Diagnostic Substances)
Bruker Corp to acquire NanoString Technologies Inc
Announced Apr 19, 2024 · Closed Jun 26, 2024
Deal value$393MEV $393M
Premium—To unaffected price
EV / Adj. EBITDA—
ConsiderationAll cash
Transaction
- Acquirer
- Bruker Corp (BRKR)
- Target
- NanoString Technologies Inc
- Buyer type
- Strategic
- Offer price per share
- —
- Enterprise value
- $393M
- Status
- Closed Jun 26, 2024
Deal protections
Not yet read from the merger agreement.
Advisors
- To the acquirer
- Not disclosed
- To the target
- Not disclosed
Sector context · Healthcare
- Comparable deals
- 105 in the prior 24 months
- Premium
- Sector median 63.0%
- EV / Adj. EBITDA
- Sector median 17.1x
- Break fee
- Sector median 3.5%
Timeline
- AnnouncedApr 19, 2024
- ClosedJun 26, 2024